Application 213301
- Type
- ANDA
- Sponsor
- UNICHEM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 50MG | No | No |
| 002 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 100MG | No | No |
| 003 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 200MG | No | No |
| 004 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213301-001 | CELECOXIB | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | ||
| A213301-002 | CELECOXIB | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | ||
| A213301-003 | CELECOXIB | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | ||
| A213301-004 | CELECOXIB | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-03-09 01:35 UTC | 2022-03 | A213301-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A213301-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A213301-003 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A213301-004 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-003 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-004 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-004 | AB | 1 | 5aa47cf7b7d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Unichem Pharmaceuticals (USA), Inc. | 0e8484a8-04a6-4be3-8c5c-1883b0490d53 | 2024-12-18 | Boxed warning, Warnings, Adverse reactions | 213301 ANDA213301 29300-157 29300-158 29300-374 29300-373 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 29300-157 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-157 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-157 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-158 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-158 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-158 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-373 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-373 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-373 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-374 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-374 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-374 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |